Results 191 to 200 of about 607,783 (212)

Cardiotoxicity of BRAF/MEK inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Rapidly accelerated fibrosarcoma type B/B‐Raf proto‐oncogene, serine/threonine kinase (BRAF) and mitogen‐activated protein kinase (MEK) inhibitors have transformed outcomes in cancer therapy, particularly in melanoma. However, cardiovascular toxicities are increasingly recognized in real‐world clinical practice.
Katharina Seuthe   +4 more
wiley   +1 more source

Cardiovascular toxicity from immune checkpoint inhibitor therapy: an inflammatory continuum

open access: yesBritish Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI) therapy has markedly improved outcomes in advanced malignancies but has also revealed a distinct spectrum of cardiovascular immune‐related adverse events. Myocarditis represents the most severe manifestation, while non‐inflammatory left ventricular dysfunction and vascular inflammation have emerged as additional ...
Fabrice Reyes   +7 more
wiley   +1 more source

Noninvasive Regional Myocardial Perfusion With Radioactive Potassium

New England Journal of Medicine, 1973
Neil D Martin   +2 more
exaly  

Long-Term Prognostic Value of 13N-Ammonia Myocardial Perfusion Positron Emission Tomography Added Value of Coronary Flow Reserve.

Journal of the American College of Cardiology, 2009
Lars Husmann   +2 more
exaly  

Dynamic Myocardial CT Perfusion Imaging for Evaluation of Myocardial Ischemia as Determined by MR Imaging.

JACC: Cardiovascular Imaging, 2014
Hans-Christoph Becker   +2 more
exaly  

Home - About - Disclaimer - Privacy